Rebecca Stokell Accepts ICC Anti-Doping Violation, Begins Voluntary Suspension
Ireland international Rebecca Stokell has admitted breaching the International Cricket Council’s anti-doping rules after a sample collected during a match tested positive for a prohibited substance. The 26-year-old batter says the matter arose from her use of prescription medication and has accepted a voluntary suspension while the disciplinary process continues.
The ICC confirmed that Stokell’s suspension took effect on October 23, 2026. Her admission and decision to suspend herself came before the process reached its final outcome. Further details about the substance, the medication involved or the potential length of any sanction have not been provided in the information released so far.
What the ICC Has Said About the Case
In its statement, the ICC said Stokell had acknowledged the anti-doping violation and accepted a voluntary suspension pending the conclusion of the disciplinary proceedings. The governing body also said the matter was connected to prescription medication.
Stokell has taken responsibility for the breach, while stressing that the medication was not used to improve her performance. She said: “I fully accept my mistake and have voluntarily entered into a period of suspension ahead of the findings being returned.”
She added that, despite the issue not being performance-related, she understood that players are responsible for complying with anti-doping requirements. Stokell also expressed hope that she would be able to return to the Ireland team as soon as possible.
Why Prescription Medication Can Raise Anti-Doping Concerns
Anti-doping rules apply to medicines as well as supplements and other substances. Some ingredients used for legitimate medical treatment may appear on the prohibited list, or may be restricted in particular circumstances. As a result, athletes are expected to check the status of any medication before taking it and, where necessary, seek approval through the relevant therapeutic-use process.
Cricket’s anti-doping framework is based on the World Anti-Doping Code. Testing may take place both during competitions and outside match periods, with samples collected for analysis under established procedures. A player can face a rule violation even if a substance was taken unintentionally or for medical reasons; the circumstances and available evidence are considered during the disciplinary process.
This is why athletes are generally advised to consult team medical staff, check official medication databases and keep records of prescriptions. Products marketed as supplements can also carry risks, since their ingredients may be unclear or contamination may occur during manufacturing. The responsibility to ensure compliance ultimately rests with the player.
Sample Collected During Ireland’s T20 World Cup Match
According to the ICC, Stokell’s sample was collected during a match on June 23, 2026. She was playing for Ireland against Sri Lanka in a T20 World Cup fixture in Bristol. Ireland lost the match by nine wickets.
Stokell scored 40 runs across the tournament, averaging 10, with an unbeaten top score of 16. The ICC’s statement, as reported, does not indicate that the alleged violation was linked to her performance in the Sri Lanka match or to any particular result. Her own comments likewise describe the matter as unrelated to performance enhancement.
The case is now subject to the applicable disciplinary process. Until that process is completed, the exact consequences for Stokell’s playing status and any eventual sanction remain uncertain. The outcome will depend on the relevant rules and the findings reached by the authorities.
Rebecca Stokell’s International Cricket Record
Stokell made her international debut for Ireland in 2017 and has represented the national side in both one-day and T20 cricket. She has played 29 women’s One-Day Internationals, scoring 468 runs at an average of 20.34 and a strike rate of 68.72. Her ODI record includes a highest score of 57 and three half-centuries.
In T20 Internationals, she has appeared in 80 matches and made 908 runs. Her average stands at 18.91, with a strike rate of 102.59. Her highest T20I score is an unbeaten 60, and she has registered one half-century in the format.
Stokell most recently featured in Ireland’s one-day series against England, which the hosts won 3–0. Her experience across formats has made her a familiar part of Ireland’s international setup, making the current suspension an important development for both the player and the team as they assess their options.
What Happens Next for Stokell and Ireland?
The immediate focus will be on the completion of the ICC’s disciplinary proceedings. A voluntary suspension means Stokell is not available to play while the process is ongoing, but it does not, by itself, establish what the final sanction will be. The decision may take into account the medication involved, the circumstances of its use and any relevant documentation or medical evidence.
For Ireland, the case may affect selection planning in upcoming international fixtures. The team will need to consider its batting options while the process continues, although Stokell’s future availability cannot be predicted until the matter is resolved. Any prediction about a return date or the length of a possible ban would be premature without a final ruling.
The case also serves as a reminder of the detailed responsibilities placed on international cricketers. Even when medication is prescribed for legitimate health reasons, players must follow anti-doping procedures and confirm that treatment complies with the rules. Stokell has acknowledged that responsibility and says she hopes to return to representing Ireland once she is permitted to do so.


